Effects of inhaled ciclesonide versus fluticasone propionate versus placebo on lower leg growth in prepubertal children with mild persistent asthma (6 to 12 y) (BY9010/M1-208)

Study identifier:BY9010/M1-208

ClinicalTrials.gov identifier:NCT00163371

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

Effect of Ciclesonide (320 mcg/day) vs Fluticasone Propionate (375 mcg/day) vs. Placebo on Short-term Linear Growth Rate and HPA-axis Function in Prepubertal Children with Mild Asthma

Medical condition

asthma

Phase

Phase 3

Healthy volunteers

No

Study drug

Ciclesonide

Sex

All

Actual Enrollment

28

Study type

Interventional

Age

6 Years - 12 Years

Date

Study Start Date: 01 Sept 2005
Primary Completion Date: 01 Dec 2005
Study Completion Date: 01 Dec 2005

Study design

Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Crossover Assignment
Masking: Double Blind
Primary Purpose: Treatment

Verification:

Verified 01 Oct 2016 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria